SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Nancy McKinney who wrote (5730)9/29/1998 11:18:00 AM
From: Linda Kaplan  Respond to of 7041
 
Nancy: It's been published. ZONA conducted some of the trials in Mexico, and after all, they did choose to go for approval there, with the intention of getting sales. Indeed, longs in this thread were touting "huge" Mexico sales, so if the sales have radically declined, that has to mean as much as the "huge" sales would have meant, don't you think?

Linda



To: Nancy McKinney who wrote (5730)9/29/1998 11:28:00 AM
From: Tokyo VD  Read Replies (1) | Respond to of 7041
 
Nancy,

I wasn't so moronic to write: "Mexico's population is predominantly peasant class. How many peasants know about drugs which enhance sexual functioning, and how many are overburdened with too many kids to feed, and are just concerned about survival on a daily basis? Sexual pleasure may not be a big priority."

So, when you ask me if I know that the "peasants" were the "guinea pigs" in the Zonagen trials, I'm going to step away from your "loaded" language and tell you that people that live in Mexico are no different than people that live in the rest of the world. Why don't you take a Civics lesson and step back from your small-mindedness to comprehend that statement. It would be more appropriate to suggest that, on the whole, the Mexican people are lower economic wage earners than Italians, but this has nothing to do with the amount of sex they prefer, nor their propensity to suffer from ED.

Now, to answer your question about sales in Mexico, Zonagen's telephone number is 281-367-5892. The company has the data on Mexican sales after the first month, but refuses to release this data. Management has admitted that sales in Mexico are down from June, its first month, but refuse to disclose any further information citing confidentiality. Confidentiality played no part in the decision to release the misleading data from June to suggest that Vasomax (Z-Max) could be competitive with Viagra.

Tokyo